Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Age-based exclusions from cardiovascular clinical trials: implications for elderly individuals (and for all of us): comment on "the persistent exclusion of older patients from ongoing clinical trials regarding heart failure".
Characteristics of primary care office systems as predictors of mammography utilization.
Body mass index, treatment practices, and mortality in patients with acute heart failure.
Expression of human amyloid precursor protein in the skeletal muscles of Drosophila results in age- and activity-dependent muscle weakness.
New developments in the pharmacologic treatment of obesity.
See All 14 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New developments in the pharmacologic treatment of obesity.
Fantasia HC. New developments in the pharmacologic treatment of obesity. Nurs Womens Health. 2013 Feb-Mar; 17(1):53-62.
View in:
PubMed
subject areas
Anti-Obesity Agents
Benzazepines
Body Mass Index
Drug Combinations
Female
Fructose
Humans
Life Style
Obesity
Phentermine
Pregnancy
Risk Assessment
United States
authors with profiles
Heidi C. Fantasia PhD, RN, WHNP-BC